Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has informed that it enclosed the transcript of the earnings conference call for the quarter ended December 31, 2023, conducted after the meeting of Board of Directors held on February 14, 2024. The above information is also available on the website of Company at https://solara.co.in/investorrelations/investor-update.
The above information is a part of company’s filings submitted to BSE.
